Hasil Pencarian  ::  Simpan CSV :: Kembali

"Penelitian survival secara historical cohort pada enam puluh dua penderita tumor ovarium borderline. Terdapat 9 penderita stadium FIGO IA, 9 stadium IC, 3 stadium IIIA, 2 stadium IIIB, 4 stadium IIIC, 1 stadium IV dan 34 stadium inadekuat. Dua puluh satu penderita dilakukan pembedahan radikal, 10 penderita hanya dilakukan histerektomi total dan salfingo-ooforektomi bilateral, 6 penderita dilakukan pembedahan konservatif, 24 penderita hanya dilakukan unilateral salfingo-ooforektomi atau kistektomi dan 1 penderita hanya biopsi saja. Enam belas penderita mendapat kemoterapi adjuvan kombinasi dengan platinum base, yaitu 8 penderita stadium inadekuat, 7 stadium III dan 1 stadium IV. Lama pengamatan lanjut antara 0,002 sampai 10,48 tahun dengan median 3,5 tahun. Lima puluh sembilan penderita tetap hidup. Tiga penderita meninggal karena penyakitnya. Residif terjadi pada 4 penderita. Ketahanan hidup penderita 2 tahun 96% dan 10 tahun 94%. Pada test ?log rank? didapatkan residu dan tipe histologi merupakan faktor prognostik yang bermakna mempengaruhi survival. (Med J Indones 2002; 11: 222-9)

---

Sixty-two patients with borderline tumors of ovary were historical cohort analyzed for survival characteristics. There were 9 patients with FIGO stage IA, 9 with stage IC, 3 with stage IIIA, 2 with stage IIIB, 4 with stage IIIC, 1 with stage IV and 34 with inadequate stage tumors. Twenty one patients had surgical staging with radical surgery, 10 patient had at least a total abdominal hysterectomy and bilateral salpingo-oophorectomy, 6 patient had surgical staging with conservative surgery, 24 patient had at least a unilateral salphingo-oophorectomy or ovarian cystectomy and 1 patient had biopsy. Sixteen patients received cisplatin-based combination chemotherapy, that were 8 with inadequate stage tumors, 7 with stage III tumors and 1 with stage IV tumor. Follow-up range from 0.02 to 10.48 years, with a median of 3.5 years. Fifty nine patient were alive. Three patients died, all of disease. Recurrence were found in 4 patients. The overall 2-years survival rate was 96% and 10-years survival rate was 94%. In log rank test, residual disease and histology type were significant predictor of survival. (Med J Indones 2002; 11:222-9)"

"Latar belakang: Kesintasan 5 tahun tumor ovarium borderline pada stadium awal cukup baik, sekitar 95-100%. Tatalaksana dari tumor ini adalah dengan pembedahan, pada pasien yang masih ingin mempertahankan fungsi reproduksinya, operasi sebisanya dilakukan dengan tetap meninggalkan uterus dan satu ovariumnya. Kemoterapi tidak dianjurkan untuk tumor ovarium borderline stadium awal. Di Indonesia penelitian tentang kesintasan tumor ovarium borderline masih sangat terbatas, oleh karena itu diperlukan penelitian lebih lanjut. Tujuan: Untuk mengetahui kesintasan tumor ovarium borderline di RSCM. Metode: Studi ini merupakan studi analitik deskriptif. Pasien yang didiagnosis dan dilakukan pembedahan di Departemen Obstetri dan Ginekologi RSCM pada periode Januari 2008-Desember 2010 dengan hasil histopatologi tumor ovarium borderline, di follow up untuk mengetahui kesintasan selama 5 tahun.Hasil: Subyek penelitian didapat 42 orang. Hasil kesintasan tumor ovarium borderline didapat sebesar 97,6%. Pada penelitian ini faktor umur, paritas, riwayat keluarga dan kontrasepsi oral, CA 125, asites, dan tindakan pembedahan didapatkan tidak mempunyai hubungan yang konsisten dengan tumor ovarium borderline. Jenis histopatologi yaitu tumor ovarium borderline serosum dan tatalaksana pembedahan tanpa dilanjutkan tindakan kemoterapi mempengaruhi kesintasan tumor ovarium borderline di RSCM dengan nilai p = 0,000 dan p = 0,001.Kesimpulan: Kesintasan 5 tahun penderita tumor ovarium borderline yang ditatalaksana di RSCM cukup baik. Tatalaksananya dititikberatkan pada pasien dengan jenis histopatologi serosum karena faktor ini mempengaruhi kesintasan 5 tahun pasien tumor ovarium borderline dan tanpa tindakan lanjutan kemoterapi hasilnya cukup baik.

---

Background: Five years survival of ovarian borderline tumors at early stage is quite good, about 95-100%. The procedures of this tumor is surgery, for patients who still want to maintain reproductive function, the best procedure by leaving the uterus and ovary. Chemotherapy is not recommended for early-stage borderline ovarian tumors. In Indonesia research on borderline ovarian tumors is limited, therefore more research is needed.Objective: To determine survival of ovarian borderline tumors in RSCM Hospital. Methode: This study is a descriptive analytic. Patients were diagnosed and surgery at Department of Obstetrics and Gynaecology RSCM on January 2008-December 2010 with a borderline ovarian tumor histopathology results, in the follow-up to determine the survival rate for 5 years, simple random sampling. Analysis of survival use Kapplan Meier Analysis.Result: The study gained 42 patients. Borderline ovarian tumor survival results obtained for 97.6%. In this study, age, parity, family history and oral contraceptive, CA 125, surgery, ascites have no consistent relationship with a borderline ovarian tumor's survival. Histopathology and chemotherapy have consistent relationship with p = 0,000 and p = 0,001.Discussion: Five years survival of patients with borderline ovarian tumors were administered in RSCM is good. It is important to pay attention to histopathology result and patient have a good survival without chemotherapy."

"ABSTRAKLatar Belakang. Terdapat gangguan sistem imun pada sepsis. Fase awal ditandaidengan hiperinflamasi, sedangkan fase lanjut ditandai dengan imunosupresi.Kematian kumulatif lebih banyak pada fase lanjut. Saat ini belum terdapatpenelitian yang secara khusus meneliti faktor prognostik mortalitas sepsis faselanjut dan mengembangkan model prediksi mortalitasnya.Tujuan. Mengetahui faktor prognostik mortalitas sepsis berat fase lanjut di ICUdan mengembangkan sistem skor untuk memprediksi mortalitas.Metode. Penelitian kohort retrospektif dilakukan pada pasien dewasa yangmengalami sepsis berat di ICU RSCM pada periode Oktober 2011 – November2012 dan masih bertahan setelah > 72 jam diagnosis sepsis ditegakkan di ICU.Tujuh faktor prognostik diidentifikasi saat diagnosis sepsis berat ditegakkan diICU. Prediktor independen diidentifikasi dengan analisis Cox’s proportionalhazard. Prediktor yang bermakna secara statistik dikuantifikasi dalam modelprediksi. Kalibrasi model dinilai dengan uji Hosmer-Lemeshow dan kemampuandiskriminasi dinilai dari area under curve (AUC) dari receiver operating curve.Hasil. Subjek penelitian terdiri atas 220 pasien. Mortalitas 28 hari sepsis beratfase lanjut adalah 40%. Faktor prognostik yang bermakna adalah alasan masukICU (medis (HR 2,75; IK95%:1,56-4,84), pembedahan emergensi (HR 1,96;IK95%:0,99 – 3,90), indeks komorbiditas Charlson > 2 (HR 2,07; IK95%:1,32-3,23), dan skor MSOFA > 4 (HR 2,84; IK95%:1,54-5,24). Model prediksimemiliki kemampuan diskriminasi yang baik (AUC 0,844) dan kalibrasi yangbaik (uji Hosmer-Lemeshow p 0,674). Berdasarkan model tersebut risikomortalitas dapat dibagi menjadi rendah (skor 0, mortalitas 5,4%), sedang (skor 1 –2,5, mortalitas 20,6%), dan tinggi (skor > 2,5, mortalitas 73,6%).Simpulan. Alasan masuk medis dan pembedahan emergensi, indeks komorbiditasCharlson > 2, dan skor MSOFA > 4 merupakan faktor prognostik mortalitassepsis berat fase lanjut di ICU RSCM. Sebuah model telah dikembangkan untukmemprediksi dan mengklasifikasikan risiko mortalitas.

---

ABSTRACTBackground. Immune system derrangement occurs during the course of sepsis,characterized by hyperinflamation in early phase and hypoinflamation andimmunosupression in late phase. The number of patient die during late phase islarger than early phase. Until now, there is no study specifically addressingprognostic factors of mortality from late sepsis and developing a mortalityprediction model.Aim. To determine prognostic factors of mortality from late phase of severesepsis in ICU and to develop scoring system to predict mortality.Method. A retrospective cohort study was conducted to identify prognosticfactors associated with mortality. Adult patients admitted to ICU duringNovember 2011 until October 2012 who developed severe sepsis and still alivefor minimum 72 hours were included in this study. Seven predefined prognosticfactors were indentified at the onset of severe sepsis in ICU. Cox’s proportionalhazard ratio was used to identify independent prognostic factors. Eachindependent factors was quantified to develop a prediction model. Calibration ofthe model was tested by Hosmer-Lemeshow, and its discrimination ability wascalculated from area under receiver operating curve.Result. Subjects consist of 220 patients. Twenty eight-day mortality was 40%.Significant prognostic factors indentified were admission source (medical (HR2.75; CI95%: 1.56 – 4.84), emergency surgery (HR 1.96; CI95%:0.99 – 3.90),Charlson comorbidity index > 2(HR 2.07; CI95%:1.32 – 3.23), and MSOFA score> 4 (HR 2.84; CI95% : 1.54 – 5.24). Prediction model developed has gooddiscrimination ability (AUC 0.844) and good calibration (Hosmer-Lemeshow testp 0.674). Based on the model mortality risk can be classified as low (score 0,mortality 5.4%), moderate (score 1 – 2.5, mortality 20.6%), and high (score > 2.5,mortality 73.6%).Conclusion. Medical and emergency surgery admission, Charlson comorbidityindex > 2, and MSOFA score > 4 were prognostic factors of mortality from latephase of severe sepsis in ICU at Dr.Cipto Mangunkusumo general hospital. Amodel has been developed to predict and classify mortality risk."

"Mortalitas pasien pneumonia di rumah sakit meningkat pada saat pandemi COVID-19. Perlu diidentifikasi faktor-faktor risikonya dari determinan biologi, gaya hidup, lingkungan dan pelayanan kesehatan. Penelitian ini menggunakan disain campuran studi kuantitatif kohort retrospektif dan studi kualitatif sequential explanatory. Sampling studi kuantitatif diambil secara acak sederhana dari rekam medis Mei 2020-Desember 2021 di RS dr. Cipto Mangunkusumo, Jakarta. Studi kualitatif berupa wawancara mendalam bersama enam orang informan. Terdapat 1945 subjek pneumonia dengan insiden kematian 34,1%. Determinan yang berhubungan dengan peningkatan risiko kematian adalah pneumonia berat (HR 1,8;IK95% 1,38-2,43), skor CCI ≥2 (HR 1,5;IK95% 1,16-2,08). komplikasi ≥2 (HR 5,9; 95%IK 2,9-11,9), intubasi (HR 1,6;IK95% 1,27-2,05) dan lama tunggu di IGD ≥8 jam (HR1,4;IK95% 1,12-1,63), tren kematian rawat inap meningkat seiring dengan bertambahnya usia. Risiko kematian lebih rendah pada subjek dengan infeksi utama selain paru (HR 0,4;IK95% 0,35-0,51), subjek yang mendapat perawatan intensif (HR 0,3;IK95% 0,25-0,41), terapi antikoagulan (HR 0,3;IK95% 0,27-0,44) dan terapi steroid pada pneumonia non-COVID-19 kondisi berat (0,7;IK95% 0,5-0,9). Ketangguhan rumah sakit terjaga dengan adanya kebijakan zonasi, penerapan prinsip mitigasi risiko, dan modulasi layanan. Beban finansial berkurang melalui donasi atau hibah. Kerentanan rumah sakit antara lain kerapuhan infrastruktur, kecepatan kembali ke layanan reguler lebih lambat, rasa takut tenaga kesehatan, dan triase pra-rumah sakit belum berjalan.Determinan biologi, lingkungan dan pelayanan kesehatan berhubungan dengan sintas rawat inap pasien pneumonia pada masa pandemi COVID-19. Ketahanan rumah sakit perlu dinilai dengan melihat dampak pandemi terhadap kematian pneumonia COVID-19 maupun pneumonia non-COVID-19.

---

In-hospital mortality of pneumonia increased during the COVID-19 pandemic. It is necessary to identify risk factors from biological determinants, lifestyle, environment and health services. This research uses a mixed design of a retrospective cohort quantitative study and a sequential explanatory qualitative study. Quantitative subjects were selected using simple random sampling based on medical records May 2020-December 2021 at Dr. Cipto Mangunkusumo Hospital, Jakarta. In-depth interviews with six informants were performed. There were 1945 pneumonia subjects with a mortality incidence of 34,1%. Determinants associated with an increased mortality risk were severe pneumonia (HR 1,8; 95% CI 1,38-2,43), CCI score ≥2 (HR 1,5; 95% CI 1,16-2,08). complications ≥2 (HR 5,9; 95% CI 2,9-11,9), intubation (HR 1,6; 95% CI 1,27-2,05) and waiting time in the ER ≥8 hours (HR1,4 ;95% CI 1,12-1,63), the trend of inpatient mortality increases with increasing age. The risk of death was lower in subjects with primary infections other than lung (HR 0,4; 95% CI 0,35-0,51), subjects receiving intensive care (HR 0,3; 95% CI 0,25-0,41), anticoagulant therapy (HR 0,3; 95% CI 0,27-0,44) and steroid therapy in severe non-COVID-19 pneumonia (0,7; 95% CI 0,5-0,9). Hospital resilience is maintained by having zoning policies, implementing risk mitigation principles, and modulating services. Financial burden is reduced through donations or grants. Hospital vulnerabilities include infrastructure fragility, slower return to regular services, fear of health workers, and pre-hospital triage not yet in place. Biological, environmental and health service determinants are related to the survival rate of pneumonia patients during the COVID-19 pandemic. Hospital resilience needs to be assessed by looking at the impact of the pandemic on mortality from COVID-19 pneumonia and non-COVID-19 pneumonia."

"Latar Belakang Defek septum atrium (DSA) adalah kelainan jantung bawaan yang memengaruhi efisiensi jantung saat septum atrium tidak menutup saat lahir. Umum terjadi pada anak-anak dan terkait dengan faktor risiko seperti Sindrom Down, kelahiran prematur, berat badan lahir rendah, usia ibu muda, riwayat keluarga penyakit jantung bawaan, paparan rokok dan paparan alkohol ibu. Meskipun berbagai profil klinis anak dengan DSA terisolasi telah diteliti namum faktor risiko DSA di RSCM belum banyak diteliti. Metode Penelitian potong lintang ini melibatkan 39 pasien DSA terisolasi berusia 0-18 tahun di RSCM, bersama dengan 39 pasien pediatrik umum sebagai kontrol. Rekam medis dipilih secara acak, dan wawancara dilakukan untuk melengkapi data. SPSS versi 27 digunakan untuk analisis data melalui uji statistik, termasuk analisis univariat dan bivariat. Hasil Kelompok DSA terisolasi umumnya terdiri dari perempuan muda dengan berat badan rendah dan bising jantung derajat-III, dan berasal dari keluarga berpenghasilan menengah-rendah. Sindrom Down (nilai-p=0,007) dan kelahiran prematur (nilaip= 0,001) merupakan faktor risiko yang signifikan secara statistik untuk DSA terisolasi dalam populasi ini. Kesimpulan Sindrom Down dan kelahiran prematur terdapat hubungan signifikan dengan DSA. Diperlukan penelitian lebih lanjut dengan sampel yang lebih besar untuk memperkuat bukti faktor risiko yang tidak signifikan secara statistik.

---

Introduction Atrial septal defect is a congenital heart defect that affects the efficiency of the heart when the atrial septum does not close at birth. It is common in children and is associated with risk factors such as Down Syndrome, premature birth, low birth weight, young maternal age, family history of congenital heart disease, smoking exposure and maternal alcohol exposure. Although various clinical profiles of children with isolated ASD have been studied, the risk factors for ASD in dr.Cipto-Mangunkusumo Hospital have not been widely studied. Method This cross-sectional study involved 39 isolated ASD patients aged 0-18 years at dr.Cipto- Mangunkusumo Hospital, along with 39 general pediatric patients as controls. Medical records were selected randomly, and interviews were conducted to complete the data. SPSS version 27 was used for data analysis through statistical tests, including univariate and bivariate analysis. Results The isolated ASD group generally consisted of young women with low body weight and grade-III heart murmurs, and came from middle/low-income families. Down syndrome (p-value=0.007) and preterm birth (p-value=0.001) were statistically significant risk factors for isolated ASD in this population. Conclusion Down syndrome and premature birth are significantly associated with isolated ASD. Further research with a larger sample is needed to strengthen the evidence for risk factors that are not statistically significant."